Effect of wild-type or mutant Parkin on oxidative damage, nitric oxide, antioxidant defenses, and the proteasome
- PMID: 12034719
- DOI: 10.1074/jbc.M200666200
Effect of wild-type or mutant Parkin on oxidative damage, nitric oxide, antioxidant defenses, and the proteasome
Abstract
Mutations in Parkin (a ubiquitin protein ligase) are involved in autosomal recessive juvenile parkinsonism, but it is not known how they cause nigral cell death. We examined the effect of Parkin overexpression on cellular levels of oxidative damage, antioxidant defenses, nitric oxide production, and proteasomal enzyme activity. Increasing expression of Parkin by gene transfection in NT-2 and SK-N-MC cells led to increased proteasomal activity, decreased levels of protein carbonyls, 3-nitrotyrosine-containing proteins, and a trend to a reduction in ubiquitinated protein levels. Transfection of these cells with DNA encoding three mutant Parkins associated with autosomal recessive juvenile parkinsonism (Del 3-5, T240R, and Q311X) gave smaller increases in proteasomal activity and led to elevated levels of protein carbonyls and lipid peroxidation. Turnover of the mutant proteins was slower than that of the wild-type protein, and both could be blocked by the proteasome inhibitor, lactacystin. A rise in levels of nitrated proteins and increased levels of NO2-/NO3- was also observed in cells transfected with mutant Parkins, apparently because of increased levels of neuronal nitric-oxide synthase. The presence of mutant Parkin in substantia nigra in juvenile parkinsonism may increase oxidative stress and nitric oxide production, sensitizing cells to death induced by other insults.
Similar articles
-
Effect of overexpression of wild-type or mutant parkin on the cellular response induced by toxic insults.J Neurosci Res. 2005 Oct 15;82(2):232-44. doi: 10.1002/jnr.20638. J Neurosci Res. 2005. PMID: 16130151
-
Effect of proteasome inhibition on cellular oxidative damage, antioxidant defences and nitric oxide production.J Neurochem. 2001 Jul;78(1):32-41. doi: 10.1046/j.1471-4159.2001.00416.x. J Neurochem. 2001. PMID: 11432971
-
Effect of overexpression of BCL-2 on cellular oxidative damage, nitric oxide production, antioxidant defenses, and the proteasome.Free Radic Biol Med. 2001 Dec 15;31(12):1550-9. doi: 10.1016/s0891-5849(01)00633-5. Free Radic Biol Med. 2001. PMID: 11744329
-
[Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].Rinsho Shinkeigaku. 2004 Apr-May;44(4-5):241-62. Rinsho Shinkeigaku. 2004. PMID: 15287506 Review. Japanese.
-
Parkin is linked to the ubiquitin pathway.J Mol Med (Berl). 2001 Sep;79(9):482-94. doi: 10.1007/s001090100242. J Mol Med (Berl). 2001. PMID: 11692161 Review.
Cited by
-
Oxidative Stress and Antioxidants in Neurodegenerative Disorders.Antioxidants (Basel). 2023 Feb 18;12(2):517. doi: 10.3390/antiox12020517. Antioxidants (Basel). 2023. PMID: 36830075 Free PMC article. Review.
-
An emerging role of PARK2 in cancer.J Mol Med (Berl). 2014 Jan;92(1):31-42. doi: 10.1007/s00109-013-1107-0. Epub 2013 Dec 3. J Mol Med (Berl). 2014. PMID: 24297497 Review.
-
Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease.Proc Natl Acad Sci U S A. 2005 May 31;102(22):8024-9. doi: 10.1073/pnas.0501078102. Epub 2005 May 23. Proc Natl Acad Sci U S A. 2005. PMID: 15911761 Free PMC article.
-
Suppression of basal autophagy reduces lung cancer cell proliferation and enhances caspase-dependent and -independent apoptosis by stimulating ROS formation.Autophagy. 2012 Jul 1;8(7):1032-44. doi: 10.4161/auto.20123. Epub 2012 May 7. Autophagy. 2012. PMID: 22562073 Free PMC article.
-
Parkin reverses intracellular beta-amyloid accumulation and its negative effects on proteasome function.J Neurosci Res. 2010 Jan;88(1):167-78. doi: 10.1002/jnr.22178. J Neurosci Res. 2010. PMID: 19610108 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials